Authorization for United States participation in the Davos Alzheimer’s Collaborative

(a) In general The United States is hereby authorized to participate in, and contribute to, the Davos Alzheimer’s Collaborative (DAC) in order to advance international efforts to prevent, diagnose, and treat Alzheimer’s disease and dementia. (b) Designee (1) In general The President is authorized to designate an employee of the relevant Federal department or agency providing the majority of United States contributions to DAC to serve on the Advisory Council of DAC and, if nominated, on the Board of Directors of DAC, as a representative of the United States. (2) Qualifications The individual to be designated pursuant to paragraph (1) should demonstrate knowledge and experience in the fields of development and public health. (3) Cooperation In carrying out this section, the individual designated pursuant to paragraph (1) shall coordinate with the USAID Administrator, the Secretary of State, and the Secretary of Health and Human Services to promote alignment, as appropriate, between DAC and United States global health and Alzheimer’s disease and dementia research and development programs. (c) United States contributions (1) In general Amounts authorized to be appropriated and made available to carry out chapters 1 and 10 of part I and chapter 4 of part II of the Foreign Assistance Act of 1961 (22 U.S.C. 2151 et seq.) are authorized to be made available for United States contributions to DAC. (2) Matching requirement Amounts made available under paragraph (1) may be obligated and expended only to the extent that DAC secures funding from sources other than the United States. At any time during fiscal years 2026 through 2030, no United States contribution to DAC may cause the total amount of United States Government contributions to DAC to exceed 33 percent of the total amount of funds contributed to the DAC from all sources. (d) Report Not later than 180 days after the date of the enactment of this Act, and on an annual basis thereafter, the President shall submit to the appropriate congressional committees a report that includes the following: (1) A description of any planned financial contributions from the United States Government to DAC. (2) The manner and extent to which the United States will participate in the governance of DAC. (3) A summary of private and governmental contributions to DAC. (4) A description of how participation in DAC supports relevant United States Government strategies and programs to combat Alzheimer’s disease and dementia and to promote global health. (e) Definition In subsection (d), the term appropriate congressional committees means— (1) the Committee on Foreign Affairs and Committee on Appropriations of the House of Representatives; and (2) the Committee on Foreign Relations and the Committee on Appropriations of the Senate.